Home / Resource Library / BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 yearsBDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 years Key points: BDR is a chemotherapy-free, non-stem-cell